This supports that RAC1B inhibition robustly impedes tumor growth and prevents Osi resistance (Figure 7), considering that elevated pERK is known to promote cell proliferation and bypass the effect of EGFT TKI.[9, 48]. This evidence concerns the gene EIF2AK3 and neoplasm.